We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Earnings Season Scorecard & Today's Top Stock Research Reports
Read MoreHide Full Article
Monday April 24, 2017
The Zacks Research Daily features the best research output of our analyst team. In today’s write-up, we are featuring analyst reports on 17 major stocks, including reports on General Electric (GE - Free Report) , Bank of America (BAC - Free Report) , UnitedHealth (UNH - Free Report) and Phillip Morris (PM - Free Report) . These reports have been hand-picked from amongst the 70 or so stock research reports published by our analyst team today. You can see all of today’s research reports here >>
In addition to these stock research reports, we are also giving you a real-time scorecard of the ongoing Q1 earnings season whose reporting pace ramps up in a big way this week with almost 800 companies coming out with quarterly results, including 191 S&P 500 members. By the end of this week, we will have crossed the halfway mark in the Q1 reporting cycle.
Including all of this morning’s releases, we now have Q1 results from 100 S&P 500 members that combined account for 25.6% of the index's total market capitalization. Total earnings for these 100 index members are up +14.1% on +4.6% higher revenues, with 74% beating EPS estimates and 62% beating revenue estimates.
This is better earnings and revenue growth performance than we have seen from this group of 100 S&P 500 members in other recent periods, even after adjusting for the strong growth from the Finance sector.
For the Finance sector, we now have Q1 results from 48.9% of the sector’s market capitalization in the S&P 500 index. Total earnings for these Finance companies are up +23% from the same period last year on +7.7% higher revenues, with 71.4% beating EPS estimates and 60.7% beating revenue estimates. This is better earnings and revenue growth rate for the Finance sector than we have seen in other recent periods.
Excluding the Finance sector, total earnings for the rest of the S&P 500 companies that have reported would be up +8% on +3.5% higher revenues from the year-earlier level.
Looking at Q1 as a whole, combining the actual results from the 100 index members with estimates from the still-to-come 400 companies, total earnings are expected to be up +9% from the same period last year on +6.6% higher revenues, the best earnings and revenue growth pace in more than two years. Excluding the Finance sector, total Q1 earnings would be up only +1% on +6.6% higher revenues.
Today’s Featured Research Reports
GE shares have struggled over the past year on concerns about the conglomerate's long-term earnings power and the issues aren't going away in response to Friday's seemingly better than expected quarterly report. The company beat EPS and revenue estimates and came out with improved industrial margins and backlog. But cash flow measures were on the weak side, highlighting once again issues of earnings quality. On the positive side, management reiterated guidance for 2017 and expects a steady rise in operating profits with a healthy ROI from the Alstom deal and the accretive Baker Hughes transaction. General Electric further aims to grow its 3D manufacturing business to $1 billion by 2020 through opportune acquisitions. To that end, it is enjoying strong momentum in the power and aviation end markets, partly offset by continued weakness in the energy space. (You can read the full research report on General Electric here >>>)
Bank of America shares have lost ground since the market's March 1st peak on policy uncertainty and downtrend in treasury yields. But the stock has turned around in recent days, with the strong Q1 earnings report helping sentiment as well. The stock is down -7.9% since March 1st vs. -1.9% decline for the S&P 500, but is still up +6.3% in the year-to-date period vs. +5% for the index. The company's efforts to streamline and simplify operations continue to enhance efficiency, narrowing the gap with its peers. But the stock's near-term performance will likely continue to reflect macro developments on the interest rate and fiscal policy fronts. (You can read the full research report on Bank of America here >>>)
UnitedHealth shares were up big on last week's strong quarterly report when it beat on the top- and bottom-lines and guided higher on the back of positive momentum in its Health Care and Optum segments. This Buy-rated stock was lagging the S&P 500 index prior to the earnings release, but has clearly broken out to the upside since then - it is up now +7.5% in the year-to-date period vs. +4.9% gain for the index. The Zacks analyst likes that fact that the company is consistently gaining from the Medicaid and Medicare businesses. Continued growth at Optum is also creating a diversified revenue source. Also, UnitedHealth should benefit from its capital strength and niche market position. But losses on public exchange business and higher operating costs are some of the headwinds. (You can read the full research report on UnitedHealth here >>>)
Philip Morris International's Q1 results lagged estimates on a bigger than expected volume drop, particularly at the low end of the market. Many analysts see the market share loss in Q1 as in-line with management's 'premium-ization' strategy and don't see it as cause for concern, but it nevertheless merits monitoring over the next few quarters, particularly given the stock's recent outperformance (PM is up +20.2% in the year-to-date period vs. +13% for the industry and +4.1% for the S&P 500 index). The stock has historically been a defensive dividend play (current yield an attractive 3.8%), but its recent performance puts it in an altogether category. Driving this momentum has been the company's improved operating outlook and expectations of greater consolidation in the space. Market participants likely need to be mindful of valuation questions as well given the stock's impressive run up, particularly in a backdrop of unfavorable currencies (all of PM's revenues come from beyond the U.S.) and market share concerns following the Q1 shortfall. (You can read the full research report on Philip Morris here >>>)
Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These sinister companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500. See today's Zacks "Strong Sells" absolutely free >>.
Sheraz Mian
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here >>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Earnings Season Scorecard & Today's Top Stock Research Reports
Monday April 24, 2017
The Zacks Research Daily features the best research output of our analyst team. In today’s write-up, we are featuring analyst reports on 17 major stocks, including reports on General Electric (GE - Free Report) , Bank of America (BAC - Free Report) , UnitedHealth (UNH - Free Report) and Phillip Morris (PM - Free Report) . These reports have been hand-picked from amongst the 70 or so stock research reports published by our analyst team today. You can see all of today’s research reports here >>
In addition to these stock research reports, we are also giving you a real-time scorecard of the ongoing Q1 earnings season whose reporting pace ramps up in a big way this week with almost 800 companies coming out with quarterly results, including 191 S&P 500 members. By the end of this week, we will have crossed the halfway mark in the Q1 reporting cycle.
You can read more about our views about this earnings season in the weekly Earnings Trends report >>> Earnings Growth Accelerates in Q1
Q1Earnings Scorecard (as of Monday, April 24th)
Including all of this morning’s releases, we now have Q1 results from 100 S&P 500 members that combined account for 25.6% of the index's total market capitalization. Total earnings for these 100 index members are up +14.1% on +4.6% higher revenues, with 74% beating EPS estimates and 62% beating revenue estimates.
This is better earnings and revenue growth performance than we have seen from this group of 100 S&P 500 members in other recent periods, even after adjusting for the strong growth from the Finance sector.
For the Finance sector, we now have Q1 results from 48.9% of the sector’s market capitalization in the S&P 500 index. Total earnings for these Finance companies are up +23% from the same period last year on +7.7% higher revenues, with 71.4% beating EPS estimates and 60.7% beating revenue estimates. This is better earnings and revenue growth rate for the Finance sector than we have seen in other recent periods.
Excluding the Finance sector, total earnings for the rest of the S&P 500 companies that have reported would be up +8% on +3.5% higher revenues from the year-earlier level.
Looking at Q1 as a whole, combining the actual results from the 100 index members with estimates from the still-to-come 400 companies, total earnings are expected to be up +9% from the same period last year on +6.6% higher revenues, the best earnings and revenue growth pace in more than two years. Excluding the Finance sector, total Q1 earnings would be up only +1% on +6.6% higher revenues.
Today’s Featured Research Reports
GE shares have struggled over the past year on concerns about the conglomerate's long-term earnings power and the issues aren't going away in response to Friday's seemingly better than expected quarterly report. The company beat EPS and revenue estimates and came out with improved industrial margins and backlog. But cash flow measures were on the weak side, highlighting once again issues of earnings quality. On the positive side, management reiterated guidance for 2017 and expects a steady rise in operating profits with a healthy ROI from the Alstom deal and the accretive Baker Hughes transaction. General Electric further aims to grow its 3D manufacturing business to $1 billion by 2020 through opportune acquisitions. To that end, it is enjoying strong momentum in the power and aviation end markets, partly offset by continued weakness in the energy space. (You can read the full research report on General Electric here >>>)
Bank of America shares have lost ground since the market's March 1st peak on policy uncertainty and downtrend in treasury yields. But the stock has turned around in recent days, with the strong Q1 earnings report helping sentiment as well. The stock is down -7.9% since March 1st vs. -1.9% decline for the S&P 500, but is still up +6.3% in the year-to-date period vs. +5% for the index. The company's efforts to streamline and simplify operations continue to enhance efficiency, narrowing the gap with its peers. But the stock's near-term performance will likely continue to reflect macro developments on the interest rate and fiscal policy fronts. (You can read the full research report on Bank of America here >>>)
UnitedHealth shares were up big on last week's strong quarterly report when it beat on the top- and bottom-lines and guided higher on the back of positive momentum in its Health Care and Optum segments. This Buy-rated stock was lagging the S&P 500 index prior to the earnings release, but has clearly broken out to the upside since then - it is up now +7.5% in the year-to-date period vs. +4.9% gain for the index. The Zacks analyst likes that fact that the company is consistently gaining from the Medicaid and Medicare businesses. Continued growth at Optum is also creating a diversified revenue source. Also, UnitedHealth should benefit from its capital strength and niche market position. But losses on public exchange business and higher operating costs are some of the headwinds. (You can read the full research report on UnitedHealth here >>>)
Philip Morris International's Q1 results lagged estimates on a bigger than expected volume drop, particularly at the low end of the market. Many analysts see the market share loss in Q1 as in-line with management's 'premium-ization' strategy and don't see it as cause for concern, but it nevertheless merits monitoring over the next few quarters, particularly given the stock's recent outperformance (PM is up +20.2% in the year-to-date period vs. +13% for the industry and +4.1% for the S&P 500 index). The stock has historically been a defensive dividend play (current yield an attractive 3.8%), but its recent performance puts it in an altogether category. Driving this momentum has been the company's improved operating outlook and expectations of greater consolidation in the space. Market participants likely need to be mindful of valuation questions as well given the stock's impressive run up, particularly in a backdrop of unfavorable currencies (all of PM's revenues come from beyond the U.S.) and market share concerns following the Q1 shortfall. (You can read the full research report on Philip Morris here >>>)
Other noteworthy reports we are featuring today include Morgan Stanley (MS - Free Report) , Qualcomm (QCOM - Free Report) and Kinder Morgan (KMI - Free Report) .
Sell These Stocks. Now.
Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These sinister companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500.
See today's Zacks "Strong Sells" absolutely free >>.
Sheraz Mian
Director of Research
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here >>>